- Home
- TEAF vs NKTR Comparison
TEAF vs NKTR Comparison
Compare TEAF & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TEAF
- NKTR
- Stock Information
- Founded
- TEAF 2017
- NKTR 1990
- Country
- TEAF United States
- NKTR United States
- Employees
- TEAF N/A
- NKTR N/A
- Industry
- TEAF Trusts Except Educational Religious and Charitable
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- TEAF Finance
- NKTR Health Care
- Exchange
- TEAF Nasdaq
- NKTR Nasdaq
- Market Cap
- TEAF 160.4M
- NKTR 108.3M
- IPO Year
- TEAF N/A
- NKTR 1994
- Fundamental
- Price
- TEAF $12.23
- NKTR $24.31
- Analyst Decision
- TEAF
- NKTR Strong Buy
- Analyst Count
- TEAF 0
- NKTR 6
- Target Price
- TEAF N/A
- NKTR $77.50
- AVG Volume (30 Days)
- TEAF 56.1K
- NKTR 4.4M
- Earning Date
- TEAF 01-01-0001
- NKTR 08-07-2025
- Dividend Yield
- TEAF 9.20%
- NKTR N/A
- EPS Growth
- TEAF N/A
- NKTR N/A
- EPS
- TEAF N/A
- NKTR N/A
- Revenue
- TEAF N/A
- NKTR $87,248,000.00
- Revenue This Year
- TEAF N/A
- NKTR N/A
- Revenue Next Year
- TEAF N/A
- NKTR N/A
- P/E Ratio
- TEAF N/A
- NKTR N/A
- Revenue Growth
- TEAF N/A
- NKTR N/A
- 52 Week Low
- TEAF $11.11
- NKTR $6.48
- 52 Week High
- TEAF $13.30
- NKTR $37.38
- Technical
- Relative Strength Index (RSI)
- TEAF 69.82
- NKTR 68.55
- Support Level
- TEAF $11.79
- NKTR $8.27
- Resistance Level
- TEAF $12.28
- NKTR $37.38
- Average True Range (ATR)
- TEAF 0.11
- NKTR 3.54
- MACD
- TEAF 0.03
- NKTR 1.72
- Stochastic Oscillator
- TEAF 90.32
- NKTR 55.75
About TEAF Ecofin Sustainable and Social Impact Term Fund
Tortoise Essential Assets Income Term is a USA-based non-diversified, closed-end management investment company. Its investment objective is to provide common shareholders with a high level of total return with an emphasis on current distributions.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.